How it works
Solutions
Culture as a service
Clone, strain & construct screening
Read more
Process development
Read more
Process characterization
Read more
Process model development
Read more
Scale-out capacity
Read more
Our bioreactors
250mL bench-scale single-use bioreactor
Read more
5L single-use bioreactor
Read more
Applications
Protein therapeutics
Read more
Viral vectors
Read more
Synthetic biology
Read more
Resources
Resources
All resources
White papers
Case studies
Documentation
Product updates
Blog posts
Announcements
Press
White paper
Continuous monitoring with Culture Biosciences 250mL Bioreactors and 908 Devices MAVERICK
Read more
White paper
Bakuchiol Synthesis Scale Up
Read more
About
Log in
Contact
White paper
Bakuchiol Synthesis Scale Up
Read more
Resources
All
White paper
Case study
Documentation
Product update
Blog post
Announcement
Press
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Announcement
Culture Biosciences And Cytiva Team Up To Innovate In Upstream Bioprocessing To Advance The Development And Manufacturing Of New Therapies
June 15, 2023
Announcement
Announcement
Culture Biosciences Establishes Advisory Board Of Biotech And Biopharma Executives To Guide The Corporate Strategy And Accelerate Growth
June 1, 2023
Announcement
Press
Surfing the Waves in Upstream Bioprocess Development – Molecule to Market Podcast with Culture’s CEO, Will Patrick
May 5, 2023
Press
Case study
MilliporeSigma Achieved Significant Increases in the Final Titers for Multiple CHOZN® Cell Lines, Using Culture Biosciences’ Cloud Bioreactor Platform
April 4, 2023
Case study
Announcement
Culture Biosciences Focuses Technology And Service Platform On Biologics
March 14, 2023
Announcement
Product update
InSiliCHO: Modeling Cell Line Dynamics for Process Development
February 24, 2023
Product update
Product update
Launching Culture’s 5L Reactors: An Interview with CEO Will Patrick
September 14, 2022
Product update
Case study
Making Bioengineering a Reality: Culture Enables Sestina’s New SynBio Platform
January 21, 2022
Case study
Announcement
Culture Biosciences Raises $80m Series B To Tackle Demand For Large-Scale Biomanufacturing
October 14, 2021
Announcement
Previous
Load more
Subscribe to our newsletter